Sonexus Health (Cardinal Health)

Overview

Sonexus Health is the specialty patient-access and hub services arm of Cardinal Health, operating as Cardinal Health Sonexus Access and Patient Support inside Cardinal Health Biopharma Solutions. It combines hub operations, case management, a noncommercial specialty pharmacy, continuous technology innovation, and 3PL distribution in one operating unit, sitting alongside Lash Group (now divested to CareMetx) and McKesson CoverMyMeds as the wholesaler-owned hub stack.

Sonexus is not a standalone independent hub; the diligence question is how its operating model integrates with - or stays separated from - the rest of Cardinal Health’s specialty distribution and pharmacy network. It is most relevant for launch teams that want access, affordability, adherence, noncommercial pharmacy, and 3PL inside a single wholesaler-owned operating contract.

Hub Capability Model

The framework below standardizes how Rx Almanac evaluates hub-services capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Sonexus is evaluated as Cardinal Health’s wholesaler-owned hub stack with non-commercial pharmacy and 3PL adjacency.

Capability	Buyer should compare	Sonexus Health readout
Therapy initiation and enrollment intake	Digital and human intake, eConsent, missing-information resolution, provider/patient portals, and clean case creation.	Core. Multi-channel enrollment, case management, guided data-driven decisions, provider / patient support, automated welcome messaging, HIPAA/TCPA consent management, and EHR integration.
Benefits verification and coverage triage	Medical/pharmacy benefit verification, eligibility checks, payer-policy lookup, coverage routing, and speed from referral to actionable case.	Core. Benefit Source proprietary eBV/ePA platform with real-time payer connectivity (PM360 Top Innovation 2019).
Prior authorization, appeals, and reimbursement casework	PA initiation, payer-specific forms, clinical documentation, appeals, denial management, and field reimbursement handoffs.	Core. Benefit Source supports ePA workflows; payer-specific algorithms reduce unnecessary rejections.
Affordability, PAP, and copay operations	Copay, free-drug, bridge, foundation, income verification, PAP renewal, and gross-to-net sensitive affordability logic.	Core. Current Cardinal packaging includes “eliminating cost concerns”; PAP, copay enrollment, free-drug, foundation navigation, and noncommercial dispensing are all in scope.
Patient engagement and adherence operations	Omnichannel reminders, clinical education, nursing or training escalation, persistence outreach, and patient-facing support quality.	Core. Current Cardinal packaging includes “helping patients succeed”; nurse and case-manager outreach, digital channels, AI-powered 24/7 patient chat, and speech analytics are part of the model.
Fulfillment, specialty pharmacy, and distribution coordination	Routing to SPs, non-commercial dispensing, DTP shipment, sample/replacement product, 3PL, and cold-chain handoffs.	Core. Noncommercial specialty pharmacy dispenses bridge product while reimbursement is resolved; Cardinal Health distribution network reaches ~90% of U.S. hospitals.
Program reporting, integrations, and governance	Manufacturer dashboards, KPI reporting, CRM/EHR/API integrations, SLA governance, and operating visibility across vendors.	Core. Speech analytics, internal SOP/PAP chatbot, and AI patient-chat deployments feed reporting; confirm dashboard cadence and API access in RFP.

Buyer Fit

• Where it fits: Include Sonexus when a manufacturer wants hub + noncommercial specialty pharmacy + 3PL under one wholesaler-owned contract, especially when Cardinal Health distribution is already part of the channel design.
• Best-fit buyers: Pharma manufacturers and biotech launch teams in Oncology, Rare Disease, and Immunology/Autoimmune specialty and biologic programs, including manufacturers exploring hybrid in-source / out-source hub models.
• Less ideal fit: Manufacturers that want a fully independent neutral hub disconnected from wholesaler distribution; cell/gene therapy programs that need a tightly bespoke white-glove rare-disease operator.
• Commercial fit: Custom/RFP; expect program-level pricing with optional hybrid and modular service models for manufacturers insourcing portions of hub work (6 hybrid manufacturers / 60 programs as of 2026).
• Coverage diligence: Confirm data firewalls between Sonexus hub data and Cardinal Health distribution data, hybrid-model governance, launch-surge staffing in Lewisville, TX, and Benefit Source payer-rule depth for your target plans.

Differentiators

• Hub + noncommercial pharmacy + 3PL in one Cardinal Health operating unit: One of the Big Three wholesaler-owned hub stacks alongside Lash Group (divested to CareMetx) and McKesson CoverMyMeds.
• Current Cardinal Sonexus packaging: Cardinal now packages Sonexus around easing patient access, eliminating cost concerns, and helping patients succeed across complex therapy journeys.
• Benefit Source eBV/ePA platform: Proprietary payer connectivity with payer-specific algorithms; PM360 Top Innovation 2019.
• Hybrid and modular hub models: Supports manufacturers insourcing portions of patient-access operations; pulse-study data shows manufacturer pressure to insource hub functions up 10 points 2024 to 2026.
• Cardinal Health distribution reach: Distribution network covers ~90% of U.S. hospitals, giving Sonexus an integrated channel handoff that hub-only vendors cannot match.
• AI patient-chat and speech analytics: 24/7 patient chat deployed March 2025; speech analytics deployed across 2025 for call analysis and journey mapping.

RFP Questions

• Which steps are performed by Sonexus directly, by a partner specialty pharmacy, by Cardinal Health distribution, and by the manufacturer?
• How are data firewalls maintained between Sonexus hub data and Cardinal Health distribution/wholesaler data?
• Which current Cardinal Sonexus solution lanes are in scope: access, affordability, adherence, reimbursement, pharmacy, clinical, technology, or comprehensive hub support?
• What median time-to-therapy, PA turnaround, and first-fill conversion metrics can be reported by brand?
• How does the hybrid/modular hub model work in practice — which functions are insourced, and how is governance handled?
• What launch-surge staffing, training, and bilingual coverage commitments are available in the first 90 days from the Lewisville, TX operations center?
• Which AI patient-chat, speech-analytics, and PAP-rule chatbot capabilities are standard versus custom?
• How does Benefit Source handle medical-benefit versus pharmacy-benefit verification for your specific payer mix?

Recent Activity

• 2026: Cardinal’s current Sonexus product page became the canonical public buyer surface, replacing the unreliable legacy standalone Sonexus domain for buyer evaluation.
• 2026: Current Cardinal materials packaged Sonexus around access, affordability, and long-term patient success, with modular support across reimbursement, pharmacy, clinical, technology, and comprehensive hub models.
• 2026-04: Sonexus published a two-year pulse study of 200 biopharma manufacturers; leadership pressure to insource hub functions increased 10 points from 2024 to 2026.
• 2026-01: FirstWord Pharma reported several leading manufacturer partners selected Sonexus for hub programs, collectively serving 1M+ patients.
• 2025-03: Launched AI-powered 24/7 patient chat solution for patient support programs.
• 2025: Deployed speech analytics platform for patient call analysis and journey mapping; internal chatbot deployed to consolidate SOPs and PAP qualification rules.
• 2014-03: Sonexus acquired by Cardinal Health Specialty Solutions (founded independently 2012).